August 27, 2014 — Philips Healthcare announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its precision planning application for transcatheter aortic valve implantation (TAVI) treatments.
August 27, 2014 — The Society of Cardiovascular Computed Tomography (SCCT) has published the “SCCT Guidelines on the Use of Coronary Computed Tomographic Angiography for Patients Presenting with Acute Chest Pain to the Emergency Department” document, printed in the July/August issue of the Journal of Cardiovascular Computed Tomography.
Cath Labs, interventional radiology suites and hospitals are continually trying to improve patient comfort as well as save time and reduce costs. With these goals in mind, Biolife introduces StatSeal Advanced Disc.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Fysicon received approval from the U.S. Food and Drug Administration (FDA) to market Fysicon DataLinQ. The Fysicon DataLinQ products enable complete automation.
August 26, 2014 — Toshiba America Medical Systems’ MR (magnetic resonance) systems have received approval to operate (ATO) with the U.S. Air Force. This makes Toshiba the only manufacturer to have fully certified MR systems (Vantage Titan 1.5T and Vantage Titan 3T) for use on the Air Force Network.
August 26, 2014 — The quality of cardiac rehabilitation programs across Canada is strong, with specific criteria areas now identified as requiring further enhancement to improve patient outcomes, according to a new study conducted by researchers at the Peter Munk Cardiac Center, York University and the University Health Network (UHN).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The mantra for treatment for high blood pressure has been "the lower, the better," but that goal can potentially put patients at risk of kidney failure or death, according to a Kaiser Permanente study published in the Journal of the American College of Cardiology.
A new therapy developed by researchers at the University of South Florida (USF) Morsani College of Medicine and Columbia University Medical Center (CUMC) may help reduce the life-threatening complications of interventional cardiovascular disease treatment.
Esaote is launching MyLab Six, a fast, accurate and highly flexible enhanced ultrasound system at ESC (European Society of Cardiology) in Barcelona, to be held Aug. 30 to Sept. 3. Configured for an extensive range of applications, MyLab Six delivers a premium quality, yet affordable, solution for shared ultrasound services across any busy clinical setting.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
New data revealing the reduction in cardiovascular (CV) deaths with Novartis' LCZ696 in patients with heart failure with reduced ejection fraction (HF-REF) will be presented at the world's largest cardiology congress, the European Society of Cardiology (ESC) Congress 2014, on Sunday, Aug. 31 at 2:30 a.m. EDT.
Esaote is launching MyLab Gamma, a best-in-class, highly portable “green” cardiovascular ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, Aug. 30-Sept. 3).
August 22, 2014 — AliveCor announced the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial fibrillation (AF), the most common form of cardiac arrhythmia. Now with the AliveCor Heart Monitor, free AliveECG app and AFib Detector, a serious medical condition can be detected entirely using a mobile device.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Biotronik announced the first implantations worldwide of its new ICD and CRT-D series (implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators).
Sunshine Heart Inc. announced that the current condition of a heart failure patient implanted with the C-Pulse System improved after six weeks of treatment, allowing him to attend his daughter's wedding.
August 21, 2014 — Christie Medical Holdings and Wolfson Children’s Hospital announced an agreement to replace all current peripheral vascular access visualization devices at the hospital with 17 VeinViewers through Christie's FreshStart program.